3 Top ETFs I Plan to Buy in April
I like to make individual investments. I love being a part owner of something tangible that can grow my wealth over the long term.
However, despite my preference for being an active investor, I've passively invested in several high-quality exchange-traded funds (ETFs). I like to use ETFs to invest in a broader theme or another area I'm not comfortable investing in individually. I plan to add to my ETF holdings this month by buying a few more shares of SPDR Biotech ETF (NYSEMKT: XBI), SPDR Portfolio High Yield Bond ETF (NYSEMKT: SPHY), and JPMorgan Equity Premium Income ETF (NYSEMKT: JEPI). Here's why I plan to buy more of these high-quality ETFs this month.
Biotechnology is an amazing sector. It has made some remarkable breakthrough discoveries, including monoclonal antibodies, CRISPR, and mRNA-based vaccines. While I'm very interested in learning about science, most of what biotechnology companies do goes over my head. Because of that, I find investing directly in biotech stocks hard. They can be very risky since drug discovery and development can often have a binary outcome.
Source Fool.com
JPMorgan Chase & Co. Stock
The stock is an absolute favorite of our community with 34 Buy predictions and no Sell predictions.
With a target price of 202 € there is a slightly positive potential of 3.69% for JPMorgan Chase & Co. compared to the current price of 194.82 €.
